Investor Presentaiton

Challenges And Opportunities By 2016, pharma in Africa reaches US$30 Bn Driven by 10% CAGR US$45 Bn by 2020 Potential of adjacent markets Market reach - owned or through trading partner Lead times vs in-country stock Late nationalisation Regulations Language and trading blocks Cross border Compliance of facilities Acquiring/retaining talent State tenders Counterfeit products Brand activation demands - Reach Need IMPERIAL HEALTH SCIENCES TM

View entire presentation